2022
DOI: 10.1016/j.biomaterials.2022.121526
|View full text |Cite
|
Sign up to set email alerts
|

Dual-functional hydrogel system for spinal cord regeneration with sustained release of arylsulfatase B alleviates fibrotic microenvironment and promotes axonal regeneration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
26
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(27 citation statements)
references
References 67 publications
1
26
0
Order By: Relevance
“…The chondroitin 4-sulfation was recognized as the critically important sulfation. Similar effects of CSPGs were detected after optic nerve injury in rodent models [132].…”
Section: Peripheral Nerve Injurysupporting
confidence: 68%
“…The chondroitin 4-sulfation was recognized as the critically important sulfation. Similar effects of CSPGs were detected after optic nerve injury in rodent models [132].…”
Section: Peripheral Nerve Injurysupporting
confidence: 68%
“…Recombinant human ARSB was reported to improve functional recovery and eliminated the observed immunoreactivity for chondroitin sulfates within five days. In other experiments, a hydrogel, which was an imidazole-polyorganophosphazene-hydrogen complex with sustained release of ARSB, significantly diminished fibrotic extracellular matrix components associated with spinal cord injury and improved functional locomotor recovery with an increased number of regenerating axons [ 105 ]. In contrast, chondroitin 6-sulfatase did not influence the extent of axon regeneration.…”
Section: Diseases With Deficiency Of Arylsulfatase Bmentioning
confidence: 99%
“…This product would be an off-the-shelf, pre-packaged and sterilized medical device to promote aligned tissue regeneration and thus restore function. Indeed, the Neuro-Spinal ([ 10 ], ClinicalTrials.gov NCT03762655) and NeuroRegen ([ 11 , 12 , 13 , 14 , 15 ], ClinicalTrials.gov NCT02510365) scaffolds currently in clinical trials are the first generation of such products. However, as their preclinical development began more than a decade ago, recent research themes were not incorporated as part of their design.…”
Section: Discussionmentioning
confidence: 99%
“…However, as their preclinical development began more than a decade ago, recent research themes were not incorporated as part of their design. Recent research themes include conductive hydrogels [ 33 ], hydrogels designed to improve the survival of transplanted stem cells [ 10 ], and hydrogels designed to modify the fibrotic microenvironment [ 11 ]. In contrast, this study is concerned with the mechanical optimisation of the hydrogel component, and importantly, combining with an aligned electrospun nonwoven for directional cues.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation